Presentation TCT 2022 TCT 729: Percutaneous Closure of Acquired Gerbode Defect after Mitral Valve Replacementt Presenter: Chad Rammohan September 18, 2022
Presentation TCT 2022 Echo Sees All – so what can we learn from echo in the CLASP Trials? Presenter: Linda Gillam September 18, 2022
Presentation TCT 2022 Insights from the CLASP IID Registry Presenter: Jörg Hausleiter September 18, 2022
Presentation TCT 2022 A Thoughtful Cardiologist Viewpoint Presenter: Allan Schwartz September 18, 2022
Presentation TCT 2022 TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT Presenter: Scott Lim September 18, 2022
Presentation TCT 2022 Midterm Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates From the Intrepid Pilot Study Presenter: Renuka Jain September 18, 2022
Presentation TCT 2022 Iatrogenic Atrial Septal Defects: Imaging and Physiologic Indications for Closure Presenter: Torsten Vahl September 18, 2022
Presentation TCT 2022 LVOT Obstruction: Prediction Models and Emerging Prevention Techniques Presenter: Mayra Guerrero September 18, 2022
Presentation TCT 2022 TMVR Performance in Real World Anatomies: Time to Consider Device Version 2.0? Presenter: Juan F. Granada September 18, 2022
Presentation TCT 2022 Outcomes Proven Through Unrivaled Clinical Experience Presenter: Andrew Morse September 18, 2022
Presentation TCT 2022 Expanding the Spectrum of TEER Suitability: Evidence from the EXPAND G4 Post Approval Study Presenter: Jason Rogers September 18, 2022
Presentation TCT 2022 Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results Presenter: Charles J. Davidson September 18, 2022
Presentation TCT 2022 Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve Presenter: Vinayak N. Bapat September 18, 2022
Presentation TCT 2022 Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study Presenter: Firas Zahr September 18, 2022